Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. Keech C, Albert G, Cho I, Robertson A, et al. N Engl J Med 2020 Sep 2. doi: 10.1056/NEJMoa2026920.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Keech C, Albert G, Cho I, Robertson A, et al. Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. N Engl J Med 2020 Sep 2. doi: 10.1056/NEJMoa2026920.
PMID: 32877576